Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
48
NCT05625568
Study of VYNT-0126 in the Treatment of Rett Syndrome in Adult Patients
Phase: Phase 2
Role: Lead Sponsor
Start: Mar 31, 2023
Completion: Jun 30, 2024